NEWMarkets
TransMedics (TMDX) Stock Price Target Raised on Strong Flight Data
Published on 6/18/2026

AI Summary
Stifel has increased its price target for TransMedics (TMDX) reflecting positive data from their flight studies. This adjustment may influence investor perception and trading volumes as it suggests a stronger performance outlook. Market reactions could vary based on how the revised target aligns with current stock performance and investor expectations. Tracking the stock's performance post-announcement will be essential for understanding its impact on market sentiment.
Related News

Earnings
Alkermes (ALKS) Price Target Increased After Narcolepsy Drug Data
Jun 18

Tech
Jabil (JBL) Stock Target Raised to $460 on AI Growth Insights
Jun 18

Markets
Lindsay (LNN) Stock Hold Rating Reiterated by Stifel After Survey
Jun 18

Markets
PebbleBrook Hotel Trust (PEB) Price Target Raised by Stifel
Jun 18